ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 140 filers reported holding ARCELLX INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,271,111 | +18.3% | 2,014,245 | +4.3% | 0.00% | +33.3% |
| Q2 2023 | $61,082,409 | +5.8% | 1,931,765 | +3.1% | 0.00% | 0.0% |
| Q1 2023 | $57,751,989 | -42.3% | 1,874,456 | -42.0% | 0.00% | 0.0% |
| Q4 2022 | $100,132,998 | +252.4% | 3,232,182 | +113.5% | 0.00% | +50.0% |
| Q3 2022 | $28,418,000 | +793.9% | 1,514,025 | +761.1% | 0.00% | – |
| Q2 2022 | $3,179,000 | +219.5% | 175,817 | +147.6% | 0.00% | – |
| Q1 2022 | $995,000 | – | 71,005 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 3,946,630 | $141,605,084 | 72.57% |
| NEA Management Company, LLC | 3,745,262 | $134,380,001 | 10.38% |
| Paradigm Biocapital Advisors LP | 2,953,122 | $105,958,017 | 7.19% |
| Samsara BioCapital, LLC | 613,921 | $22,027,485 | 6.74% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,869,967 | $102,974,416 | 5.56% |
| Perceptive Advisors | 3,965,978 | $142,299,291 | 4.75% |
| Cormorant Asset Management, LP | 2,150,000 | $77,142,000 | 4.50% |
| Affinity Asset Advisors, LLC | 400,000 | $14,352,000 | 4.04% |
| Novo Holdings A/S | 1,075,000 | $38,571,000 | 2.85% |
| Soleus Capital Management, L.P. | 643,777 | $23,098,719 | 2.13% |